A detailed history of Fine Mark National Bank & Trust transactions in Pfizer Inc stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 211,998 shares of PFE stock, worth $5.67 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
211,998
Previous 216,967 2.29%
Holding current value
$5.67 Million
Previous $6.07 Million 1.07%
% of portfolio
0.22%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $137,641 - $155,976
-4,969 Reduced 2.29%
211,998 $6.14 Million
Q2 2024

Aug 02, 2024

SELL
$25.26 - $29.6 $896,098 - $1.05 Million
-35,475 Reduced 14.05%
216,967 $6.07 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $492,350 - $565,375
-19,017 Reduced 7.01%
252,442 $7.01 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $492,759 - $640,040
-18,858 Reduced 6.5%
271,459 $7.82 Million
Q3 2023

Nov 15, 2023

SELL
$32.09 - $37.51 $572,325 - $668,990
-17,835 Reduced 5.79%
290,317 $9.63 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $7,079 - $8,190
-196 Reduced 0.06%
308,152 $11.3 Million
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $19,064 - $24,819
484 Added 0.16%
308,348 $12.6 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $849,111 - $1.11 Million
-20,338 Reduced 6.2%
307,864 $15.8 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $258,621 - $315,712
-5,910 Reduced 1.77%
328,202 $14.4 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $268,664 - $318,551
-5,774 Reduced 1.7%
334,112 $17.5 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $4.02 Million - $4.98 Million
-87,760 Reduced 20.52%
339,886 $17.6 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $41,857 - $62,046
-1,013 Reduced 0.24%
427,646 $25.3 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $73,201 - $94,033
-1,865 Reduced 0.43%
428,659 $18.4 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $30,092 - $34,089
-838 Reduced 0.19%
430,524 $16.9 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $67,080 - $75,653
-2,003 Reduced 0.46%
431,362 $15.6 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $225,955 - $287,322
-6,751 Reduced 1.53%
433,365 $16 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $16,414 - $19,258
-517 Reduced 0.12%
440,116 $16.2 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $77,559 - $94,090
2,575 Added 0.59%
440,633 $14.4 Million
Q1 2020

May 06, 2020

BUY
$27.03 - $38.62 $183,236 - $261,804
6,779 Added 1.57%
438,058 $14.3 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $314,912 - $357,385
9,566 Added 2.27%
431,279 $16.9 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $37,103 - $48,112
1,142 Added 0.27%
421,713 $14.4 Million
Q2 2019

Aug 08, 2019

BUY
$36.98 - $41.52 $528,592 - $593,486
14,294 Added 3.52%
420,571 $18.2 Million
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $418,162 - $459,421
-11,151 Reduced 2.67%
406,277 $17.3 Million
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $202,736 - $231,142
5,270 Added 1.28%
417,428 $18.2 Million
Q3 2018

Nov 02, 2018

SELL
$34.47 - $41.81 $498,022 - $604,070
-14,448 Reduced 3.39%
412,158 $18.2 Million
Q2 2018

Aug 03, 2018

BUY
$32.98 - $35.16 $331,119 - $353,006
10,040 Added 2.41%
426,606 $15.5 Million
Q1 2018

Apr 26, 2018

BUY
$31.91 - $37.02 $192,513 - $223,341
6,033 Added 1.47%
416,566 $14.8 Million
Q4 2017

Jan 30, 2018

BUY
$33.26 - $35.29 $214,227 - $227,302
6,441 Added 1.59%
410,533 $14.9 Million
Q3 2017

Oct 30, 2017

BUY
$31.0 - $34.15 $12.5 Million - $13.8 Million
404,092
404,092 $14.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.